Major pharma companies sign up to groundbreaking Parkinson's consortium
25-Feb-2016 -
Seven of the world's largest pharmaceutical companies have signed up to a groundbreaking consortium aimed at accelerating the development of safe and effective therapies for Parkinson's.
The Critical Path for Parkinson's consortium will bring together leading academics; industry members AbbVie, ...
AstraZeneca
collaborations
Eli Lilly
+4